Here are three things to know:
1. Spinal Elements received FDA clearance in November for its Ti-Bond surface coating technology. The company’s portfolio includes a number of products featuring Ti-Bond, such as the Lucent XP height- and lordosis-expandable interbody device.
2. The company’s Clutch interspinous process device features a proprietary spring-activated mechanism designed to maintain active compression against the spinous processes to resist loosening and migration.
3. Jason Blain is a founder, president and CEO of Spinal Elements. Mr. Blain has nearly 20 years of experience in orthopedics.
More articles on devices:
ZygoFix begins human clinical trial of spinal facet joint fixation system: 4 things to know
What Morgan Stanley thinks of Smith & Nephew’s new CEO: 5 things to know
Moody’s report shows positive outlook for US medical device sector in 2019 — 5 insights
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
